Business Wire

Innovative Design Cuts CO2 Emissions in Data Centers

Share

Huawei’s ability to build more energy-efficient data centers could be an example to others as decarbonization of the construction sector picks up worldwide, according to a company spokesperson.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121005364/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Andrew Williamson, Vice President of Government Affairs and Economic Advisor, Huawei speaks at the panel. (Photo: Business Wire)

Andrew Williamson, Vice President of Government Affairs and Economic Advisor at Huawei, said “smart” digital infrastructure and buildings are becoming especially common in China’s Guangdong–Hong Kong–Macao Greater Bay Area (GBA).

“The modularization of data center facilities creates new possibilities for fast construction and with a lower carbon footprint,” said Williamson, who stressed that construction times can be reduced to six months from 18 months, thanks to steel prefabricated design.

“This solution uses much less concrete than conventional buildings, and carbon emissions in the construction phase could be offset by more than 90 percent,” he said.

Williamson made the remarks as he addressed a session organized by the Global Alliance for Buildings and Construction (GlobalABC) and German Energy Agency at the Buildings Pavilion during the ongoing 27th Conference of the Parties, or COP27, in Sharm El-Sheikh, Egypt. The session also included speakers from the German Federal Ministry for Economic Affairs and Climate Action (BMWK), the Chinese Academy of Building Research, the World Resources Institute, ICLEI East Asia, Shenzhen Institute of Building Research and JA Solar.

“The process itself is really important to get collaboration in motion in the decarbonization of the buildings sector. Essentially it is about bringing the different actors together, getting them to talk to each other and agree on a shared vision and some targets, and to agree on the actions that need to be implemented to transform the sector,” said Jonathan Duwyn, Head of Buildings and Construction Portfolio at the United Nations Environment Programme.

In terms of building green and eco-friendly campuses, Huawei has adopted rooftop photovoltaics (PVs) for many of its own facilities, including the Huawei Dongguan Southern Factory. It has also consistently increased the use of electricity from renewable energy sources, which rose by 42.3 percent to 300 million kWh in 2021.

In its headquarters in Shenzhen and Dongguan of China’s GBA area, Huawei’s campuses are both fully powered by clean energy. Elsewhere in the country, the Chengdu Research Center was the first of its kind for the company to achieve net-zero carbon operations.

The company has also contributed in the concerted global effort to power COP27 with clean solar energy. Together with its partner Infinity Power, Huawei supplied all string inverters to the 6MW solar project that has lit up the COP27 conference center.

The solar plant is expected to generate up to 11,723 MWh of energy a year. That can power 5,000 homes and reduce 4,000-plus tons of CO2 emissions annually.

“The project will also provide green electricity to Sharm el-Sheikh for years to come,” said Williamson.

About Huawei

Founded in 1987, Huawei is a leading global provider of information and communications technology (ICT) infrastructure and smart devices. We have 195,000 employees and we operate in more than 170 countries and regions, serving more than three billion people around the world.

Our vision and mission is to bring digital to every person, home and organization for a fully connected, intelligent world. To this end, we will work towards ubiquitous connectivity and inclusive network access, laying the foundation for an intelligent world; provide diversified computing power where you need it, when you need it, to bring cloud and intelligence to all four corners of the earth; build digital platforms to help all industries and organizations become more agile, efficient, and dynamic; and redefine user experience with AI, making it smarter and more personalized for people in all aspects of their life, whether they're at home, on the go, in the office, having fun, or working out. For more information, please visit Huawei online at www.huawei.com or follow us on:

http://www.linkedin.com/company/Huawei
http://www.twitter.com/Huawei
http://www.facebook.com/Huawei
http://www.youtube.com/Huawei

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Huawei, Francis Yang, +86 13871384929, yangmingxi1@huawei.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye